Convergence of Human Genetics and Animal Studies: Gene Therapy for X-Linked Retinoschisis.
暂无分享,去创建一个
P. Sieving | L. Wei | R. Bush
[1] P. Sieving,et al. Molecular modeling indicates distinct classes of missense variants with mild and severe XLRS phenotypes. , 2013, Human molecular genetics.
[2] G. Holder,et al. A phenotype-genotype correlation study of X-linked retinoschisis. , 2013, Ophthalmology.
[3] Deniz Dalkara,et al. In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous , 2013, Science Translational Medicine.
[4] C. Grimm,et al. In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition. , 2012, Veterinary Ophthalmology.
[5] B. Weber,et al. X-linked juvenile retinoschisis: Clinical diagnosis, genetic analysis, and molecular mechanisms , 2012, Progress in Retinal and Eye Research.
[6] R. Ali,et al. Ocular gene delivery using lentiviral vectors , 2011, Gene Therapy.
[7] P. Sieving,et al. X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects. , 2011, Investigative ophthalmology & visual science.
[8] L. Vandenberghe,et al. Novel adeno-associated viral vectors for retinal gene therapy , 2011, Gene Therapy.
[9] J. Flannery,et al. AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] W. Hauswirth,et al. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] G. Veres,et al. Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] P. Sieving,et al. Molecular Modeling of Retinoschisin and Functional Analysis of Pathogenic Mutations From X-Linked Retinoschisis , 2010 .
[13] P. Sieving,et al. Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis. , 2010, Human molecular genetics.
[14] W. Hauswirth,et al. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency , 2010, Gene Therapy.
[15] Jean Bennett,et al. Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] Kathleen A. Marshall,et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial , 2009, The Lancet.
[17] P. Sieving,et al. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse , 2009, Gene Therapy.
[18] W. Hauswirth,et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Kenneth I. Berns,et al. Gene Therapy Using Adeno-Associated Virus Vectors , 2008, Clinical Microbiology Reviews.
[20] W. Hauswirth,et al. Phase I Trial of Leber Congenital Amaurosis due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results , 2008 .
[21] Kathleen A. Marshall,et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[22] Nick Tyler,et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[23] Tomohiro Iida,et al. Resolution of retinoschisis after vitreous surgery in X-linked retinoschisis. , 2008, Ophthalmology.
[24] P. Sieving,et al. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration. , 2007, Investigative ophthalmology & visual science.
[25] M. Trese,et al. Congenital X-Linked Retinoschisis: Structural and Genetic Evaluation Using a New Classification System , 2007 .
[26] P. Sieving,et al. Retinoschisin is a peripheral membrane protein with affinity for anionic phospholipids and affected by divalent cations. , 2007, Investigative ophthalmology & visual science.
[27] P. Sieving,et al. Identification and characterization of two mature isoforms of retinoschisin in murine retina. , 2006, Biochemical and biophysical research communications.
[28] M. Kay,et al. The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 , 2006, Journal of Virology.
[29] G. Fishman,et al. USE OF DORZOLAMIDE FOR PATIENTS WITH X-LINKED RETINOSCHISIS , 2006, Retina.
[30] C. Ford,et al. Sensing extracellular matrix: an update on discoidin domain receptor function. , 2006, Cellular signalling.
[31] P. Campochiaro,et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. , 2006, Human gene therapy.
[32] W. Mieler,et al. Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] W. Hauswirth,et al. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[34] Robert W. Williams,et al. An ENU-induced mutation in Rs1h causes disruption of retinal structure and function. , 2005, Molecular vision.
[35] T. Kanda,et al. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. , 2004, Virology.
[36] P. Sieving,et al. A retinal neuronal developmental wave of retinoschisin expression begins in ganglion cells during layer formation. , 2004, Investigative ophthalmology & visual science.
[37] P. Sieving,et al. RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis. , 2004, Investigative ophthalmology & visual science.
[38] Giovanni Di Pasquale,et al. Identification of PDGFR as a receptor for AAV-5 transduction , 2003, Nature Medicine.
[39] A. Ciccodicola,et al. Clinical features of X linked juvenile retinoschisis associated with new mutations in the XLRS1 gene in Italian families , 2003, The British journal of ophthalmology.
[40] R. Molday,et al. Defective Discoidin Domain Structure, Subunit Assembly, and Endoplasmic Reticulum Processing of Retinoschisin are Primary Mechanisms Responsible for X-linked Retinoschisis* , 2003, Journal of Biological Chemistry.
[41] D. Farber,et al. Retinoschisin, a Photoreceptor-Secreted Protein, and Its Interaction with Bipolar and Müller Cells , 2003, The Journal of Neuroscience.
[42] P. McDonnell,et al. Phase I/II evaluation of safety and efficacy of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct (Md-dnG1) as adjunctive intervention for superficial corneal opacity/corneal scarring. , 2003, Human gene therapy.
[43] J. Chiorini,et al. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. , 2002, Human gene therapy.
[44] M. Seeliger,et al. Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] B. Weber,et al. Expression of X-linked retinoschisis protein RS1 in photoreceptor and bipolar cells. , 2001, Investigative ophthalmology & visual science.
[46] P. Sieving,et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. , 2000, Investigative ophthalmology & visual science.
[47] P. Sieving,et al. Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene. , 2000, Archives of ophthalmology.
[48] Juliet A. Ellis,et al. Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. , 1999, Human molecular genetics.
[49] C. Kozak,et al. The mouse X-linked juvenile retinoschisis cDNA: expression in photoreceptors. , 1999, Gene.
[50] P. Sieving,et al. Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis (XLRS) , 1998 .
[51] R. Samulski,et al. Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.
[52] J. Bennett,et al. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. , 1997, Investigative ophthalmology & visual science.
[53] B. Lorenz,et al. Positional cloning of the gene associated with X-linked juvenile retinoschisis , 1997, Nature Genetics.
[54] A. Moore,et al. X linked retinoschisis. , 1995, The British journal of ophthalmology.
[55] A. Munnich,et al. Contribution to carrier detection and genetic counselling in X linked retinoschisis. , 1991, Journal of medical genetics.
[56] M. Brigell,et al. Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis. , 1987, Archives of ophthalmology.
[57] I. Mann,et al. CONGENITAL VASCULAR VEILS IN THE VITREOUS , 1938, The British journal of ophthalmology.
[58] Marjan Wilczek. Ein Fall der Netzhautspaltung (Retinoschisis) mit einer öffnung , 1935 .
[59] A. Heiligenhaus. Acetazolamide in the Treatment of X-Linked Retinoschisis Maculopathy , 2007 .
[60] R. Samulski,et al. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. , 1999, Nature medicine.
[61] P. Sieving,et al. Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease. , 1999, Transactions of the American Ophthalmological Society.
[62] R. Samulski,et al. αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection , 1999, Nature Medicine.
[63] S. Walpole. Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis. The Retinoschisis Consortium. , 1998, Human molecular genetics.
[64] C. Giraud,et al. Biology of adeno-associated virus. , 1996, Current topics in microbiology and immunology.